Market Overview

Benzinga's Top Downgrades

Related BAX
Halozyme Therapeutics Receives Favorable FDA Decision
Stocks Mixed Despite Better Than Expected GDP
Merck Snags Baxter Executive As CFO (Fox Business)
Related CVC
UPDATE: Citigroup Downgrades Cablevision Systems
Brean Capital Sees M&A In Future For Cablevision Systems
J-Lo-Backed Network Outbids 'Diddy' for Fuse (Fox Business)

Analysts at Mizuho downgraded Baxter International (NYSE: BAX) from “buy” to “neutral.” Baxter's shares closed at $66.84 yesterday. Baxter's trailing-twelve-month profit margin is 16.36%.

Analysts at Canaccord downgraded Cablevision Systems (NYSE: CVC) from “buy” to “hold.” Cablevision's shares closed at $14.02 yesterday. Cablevision's trailing-twelve-month ROA is 9.77%.

Analysts at RBC Capital downgraded McMoRan Exploration Co (NYSE: MMR) from “outperform” to “sector perform.” McMoRan Exploration's shares closed at $9.65 yesterday. McMoRan Exploration's PEG ratio is -4.48.

Bernstein downgraded Boston Scientific (NYSE: BSX) from “outperform” to “market perform.” Boston Scientific's shares closed at $5.66 yesterday. Boston Scientific's trailing-twelve-month ROE is -43.84%.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (BAX + BSX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters